Retatrutide

A triple GIP / GLP-1 / glucagon receptor agonist and one of the most potent metabolic compounds currently under study.

What it is

Retatrutide is a single-molecule agonist that engages three incretin and metabolic receptors at once, GIP, GLP-1 and glucagon. By combining all three pathways it is studied as a next-generation metabolic research compound, building on the dual-agonist work that came before it.

What the research looks at

In research models, retatrutide is investigated for metabolic regulation, weight management and glycemic control. Activating the GLP-1 and GIP receptors is associated with incretin signalling, while adding glucagon-receptor activity is studied for its effect on energy expenditure, the combination is what makes it one of the most potent metabolic compounds under study.

Supplied strictly for laboratory research use only, not for human or veterinary use.

At a glance

Preparing it

Reconstitute the lyophilized powder with bacteriostatic or sterile water, drawn slowly down the side of the vial and swirled, never shaken, until fully dissolved. The volume of water you add sets the concentration of the solution.

For the full procedure see reconstitution, and to work out concentration per unit see concentration & math.

Where to go next